Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

0.6232 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corp ADR

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
From Amarin Corporation plc
Via GlobeNewswire
Amarin Reports Second Quarter 2023 Financial Results
From Amarin Corporation plc
Via GlobeNewswire
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus’ Established Commercial and Marketing Expertise in the Region 
From Amarin Corporation plc
Via GlobeNewswire
Why Amarin Stock Is Sinking Today
The drugmaker announced a major corporate reorganization and a new CEO. 
Via The Motley Fool
Amarin Corp's Return On Capital Employed Insights
Via Benzinga
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript
AMRN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
From Amarin Corporation plc
Via GlobeNewswire
Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain
From Amarin Corporation plc
Via GlobeNewswire
Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt
From Amarin Corporation plc
Via GlobeNewswire
Recap: Amarin Corp Q1 Earnings
Via Benzinga
Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also... 
Via Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,... 
Via Benzinga
Why Are Amarin Shares Plunging Today?
Amarin Corporation plc (NASDAQ: AMRN) shares are down after the company on Tuesday announced that it was restructuring in an effort to reduce operating costs by approximately  
Via Benzinga
Dow Rises Over 100 Points; Goldman Sachs Earnings Miss Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 35,082.94 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why bluebird bio Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares surged 23.6% to $2.99 in pre-market trading after dipping 21% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday! 
Via InvestorPlace
Omnicom, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Amarin Appoints Patrick Holt as President and Chief Executive Officer
From Amarin Corporation plc
Via GlobeNewswire
Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient Access to VASCEPA®/VAZKEPA® Globally
From Amarin Corporation plc
Via GlobeNewswire
Morgan Stanley, Charles Schwab, Bank of America, And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Dow Jones gaining over 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Present at Two Upcoming Investor Conferences
From Amarin Corporation plc
Via GlobeNewswire
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
From Amarin Corporation plc
Via GlobeNewswire
3 Biotech Stocks to Avoid Like the Plague
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events
From Amarin Corporation plc
Via GlobeNewswire
Amarin Reports Stable Revenue, Cash Position In Q1 But Lowers FY23 Operating Expense Guidance: What's Next?
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.